Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthes-Stratec buys spinal gel company Gelifex:

This article was originally published in Clinica

Executive Summary

Synthes-Stratec's US business has acquired a company that is developing hydrogels to treat degenerative disc disease. Gelifex, founded in 2002 by two professors at Drexel University in Philadelphia, Pennsylvania, is one of many seeking to commercialise alternatives to spinal fusion. Its technology is designed for implantation or injection into the space between vertebrae to restore motion and alleviate pain. A three-year Gelifex research project will continue at Drexel University at Synthes's expense. Gelifex was founded by Professors Tony Lowman of Drexel's chemical engineering department and Michele Marcolongo of materials science and engineering.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057932

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel